Page last updated: 2024-09-05

ly 300164 and Brain Infarction

ly 300164 has been researched along with Brain Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrási, F; Berzsenyi, P; Erdo, F	1

Other Studies

1 other study(ies) available for ly 300164 and Brain Infarction

Article	Year
The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia. Brain research bulletin, 2005, Jul-15, Volume: 66, Issue:1 Topics: Animals; Benzodiazepines; Brain Infarction; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Rose Bengal; Tetrazolium Salts; Time Factors	2005

Article

Year

The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.

Brain research bulletin, 2005, Jul-15, Volume: 66, Issue:1

Topics: Animals; Benzodiazepines; Brain Infarction; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Rose Bengal; Tetrazolium Salts; Time Factors

2005